Ads
related to: the 2020 focused updates to nih asthma management guidelines racgp list- Home
Official Patient Website—
Get Treatment Info Today.
- Sign Up
Register Or Activate Your Card—
Find Out If You're Eligible Today.
- Register For A Webinar
Learn From Medical Professionals
Hear From Real Patients Like You
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Home
Search results
Results From The WOW.Com Content Network
The Global Initiative for Asthma (GINA) is a medical guidelines organisation which works with public health officials and health care professionals globally to reduce asthma prevalence, morbidity, and mortality. GINA was launched in 1993 as a collaboration between National Heart, Lung, and Blood Institute, National Institutes of Health, and the ...
Anti-asthmatic agents. Anti-asthmatic agents refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related ...
The Royal Australian College of General Practitioners (RACGP) is the professional body for general practitioners (GPs) in Australia. The RACGP is responsible for maintaining standards for quality clinical practice, education and training, and research in Australian general practice. The RACGP represents over 40,000 members across metropolitan ...
Acute severe asthma, also known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators (inhalers) and corticosteroids. [2] Asthma is caused by multiple genes , some having protective effect, with each gene having its own tendency to be influenced by the environment although a ...
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States.It is tasked with allocating about $3.6 billion in FY 2020 [1] in tax revenue to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease ...
Long-acting β adrenoceptor agonists (LABAs) are beta-adrenergic agonists usually prescribed for moderate-to-severe persistent asthma and chronic obstructive pulmonary disease (COPD). LABAs are designed to reduce the need for shorter-acting β 2 agonists such as salbutamol (albuterol), as they have an approximately twelve-hour duration of ...
Ad
related to: the 2020 focused updates to nih asthma management guidelines racgp list